Liver Failure

Positive preclinical data reported on blood purification device

Published in Blood Weekly, August 12th, 2004

Arbios Systems, Inc., (ABOS), a biomedical device company engaged in the development of proprietary liver assist technologies useful in the treatment of acute liver failure, announced the results of two preclinical studies using its proprietary SEPET device.

The SEPET device is a single-use hollow-fiber cartridge designed to provide extracorporeal blood purification therapy for patients with acute liver failure. SEPET is designed to work with standard kidney dialysis machines for removal of the plasma fraction in blood containing toxins of hepatic failure.

One of the preclinical studies was designed to examine the effect of SEPET therapy on safety...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2004-08-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry